Marathon Asset Management 13F: Cuts InMode (INMD) Stake by $2.1M

Marathon Asset Management reduced its holdings in InMode Ltd. (NASDAQ: INMD) by 149,778 shares, as disclosed in a filing on October 26, 2026. This move decreased their position by approximately 96.8%, leaving them with a total of 4,910 shares valued at around $69,575. The reported value of Marathon's entire portfolio is about $1.26 billion.

INMD InMode Ltd.

$13.72 ▼ -7.30% year to date

1M 3M YTD

Daily close · Oct 26, 2026

Where InMode Fits in Marathon's Portfolio

InMode represents a small part of Marathon Asset Management's portfolio, accounting for just 0.01%. The recent reduction has significantly shrunk their stake, indicating a shift in their investment strategy regarding this stock.

Other Institutional Activity in InMode

Doma Perpetual Capital Management LLC reduced its holdings by 336,497 shares, ending with 2,730,931 shares valued at about $37.5 million. Acadian Asset Management LLC also trimmed its stake by 9,336 shares, leaving it with 2,583,988 shares worth approximately $35.5 million. Renaissance Technologies, LLC cut its holdings by 195,009 shares, now holding 2,391,318 shares valued at about $32.8 million.

InMode Ltd. Stock Down 2.3%

InMode shares recently traded around $13.72, reflecting a notable change from earlier trading levels. The stock's performance is significant as it may influence investor sentiment following this reduction in Marathon's holdings.

Recent Earnings

InMode reported trailing twelve-month revenue of approximately $374.6 million and earnings per share of $1.20. The company has a net margin of 20.7% and a return on equity of 12.3%. Their next earnings report is scheduled for November 11, 2026.

Insider Buying and Selling at InMode Ltd.

There are currently no reported insider transactions for InMode Ltd.

Analysts Set New Price Targets

There is no recent analyst coverage or new price targets available for InMode at this time.

About InMode

InMode Ltd. designs and manufactures minimally invasive aesthetic medical products, focusing on technologies that enhance cosmetic procedures. The company's innovations are marketed in the U.S., Europe, Asia, and other regions, making it a key player in the medical devices industry.

Bottom Line

Investors should keep an eye on InMode's upcoming earnings report on November 11, 2026, as well as any further filings from Marathon Asset Management regarding this stock. This recent cut in holdings may signal a shift in how the fund views InMode's future prospects.